Boai NKY Medical Holdings Ltd. (SHE:300109)
China flag China · Delayed Price · Currency is CNY
13.96
-0.04 (-0.29%)
Sep 4, 2026, 3:04 PM CST

Boai NKY Medical Holdings Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
154.02190.09349.68493.03291.46207.05
Depreciation & Amortization
91.54103.1102.0974.2261.9471.88
Other Amortization
11.811.12.954.773.94.32
Loss (Gain) From Sale of Assets
3.21-2.46-0.09-0.040.870.46
Asset Writedown & Restructuring Costs
53.2141.6546.370.360.1160.63
Loss (Gain) From Sale of Investments
-3.25-3.2812.231.0737.83-201.64
Provision & Write-off of Bad Debts
---9.6145.8211.7
Other Operating Activities
3.333.336.49-5.03-2.2536.49
Change in Accounts Receivable
514.6188.41-27.84-57.81-163.959.25
Change in Inventory
120.3159.09-71.62-61.94-10.26-39.3
Change in Accounts Payable
-593.64-171.43-181.5232.2710.25-104.68
Change in Other Net Operating Assets
22.6522.6528.58-4.23-3.7-0.63
Operating Cash Flow
363.98338.11256.03488.25251.7743.44
Operating Cash Flow Growth
111.31%32.06%-47.56%93.93%479.57%-83.72%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-177.07-220.42-274.68-377.88-266-228.32
Sale of Property, Plant & Equipment
10.1130.040.170.4215.81
Divestitures
--4.958.9301,970
Investment in Securities
255.43260.43174.56-175.86549.93254.98
Other Investing Activities
-291.05----587.08-482.5
Investing Cash Flow
-202.5853.01-95.14-544.64-302.721,530

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-445.46626.7914.9826.68607.68
Short-Term Debt Repaid
------30
Long-Term Debt Repaid
--568.56-238.43-27.34-36.33-1,289
Total Debt Repaid
-420.13-568.56-238.43-27.34-36.33-1,319
Net Debt Issued (Repaid)
9.75-123.11388.35-12.37-9.65-711.66
Issuance of Common Stock
1.351.350.9-15.1119.4
Repurchase of Common Stock
---1.9-7.08-400.07-3.4
Common Dividends Paid
-222.99-129.32-328.78-164.26-169.97-41.49
Other Financing Activities
-348.70.040.06---
Financing Cash Flow
-560.6-251.0558.63-183.71-564.59-637.15

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
3.8812.14.872.023.862.58
Net Cash Flow
-395.31152.18224.4-238.07-611.68938.42

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
186.91117.69-18.65110.37-14.23-184.88
Free Cash Flow Growth
------
Free Cash Flow Margin
15.42%9.99%-1.16%6.97%-0.96%-15.15%
Free Cash Flow Per Share
0.320.20-0.030.19-0.02-0.31
Levered Free Cash Flow
253.33240.11-72.5524.6-25.77136.38
Unlevered Free Cash Flow
258.07244.85-68.1525.89-24.13159.96

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
66.3757.4783.63240.09147.8962.9
Change in Working Capital
50.11-5.41-263.69-89.73-187.92-147.44